𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice

✍ Scribed by Axel Kornerup Hansen; Fengjun Ling; Anne Kaas; David P. Funda; Helene Farlov; Karsten Buschard


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
105 KB
Volume
22
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

A gluten‐free diet reduces the incidence of diabetes mellitus in non‐obese diabetic (NOD) mice, but the mechanism is not known. The aim of this study was to examine the possible influence of the diet on the caecal bacterial flora, which may affect the intestinal physiology and mediate disease prevention.

Methods

Two groups of NOD mice from the age of 3 weeks were fed either a gluten‐free diet or a standard diet. Each diabetic mouse, when diagnosed, along with a non‐diabetic mouse from the same diet group and two non‐diabetic mice from the alternate diet group were euthanized and sampled for classical bacteriological examination.

Results

Nine out of 19 (47%) standard‐fed mice and 1 out of 19 (5%) gluten‐free‐fed mice developed diabetes (p < 0.01). Mice on the gluten‐free diet had significantly fewer aerobically (p < 0.01) and microaerophilically (p < 0.001) cultivated bacteria in their intestines than standard‐fed mice. Non‐diabetic mice also had significantly fewer microa erophilic and anaerobic bacteria than diabetic mice (p < 0.05). These differences were primarily due to a difference in the Gram‐positive flora.

Conclusions

The gluten‐free diet compared to the standard diet both qualitatively and quantitatively substantially altered the composition of the caecal bacterial flora in NOD mice. Although Gram‐positive bacteria might influence the beta cells through certain digestive products, it is more likely to assume that any effect on diabetes incidence is immunological. Copyright © 2005 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Diet can influence the ability of nicoti
✍ P.E. Beales; L.A. Burr; G.P. Webb; K.J. Mansfield; P. Pozzilli 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

Background The non-obese diabetic (NOD) mouse is a widely used model of Type 1 diabetes mellitus (Type 1 DM), which displays many of the characteristics of the disease found in humans. Nicotinamide (NA) is currently being tested in large-scale, multi-centre human trials for the prevention of Type 1

Heparanase prevents the development of t
✍ Menachem Bitan; Lola Weiss; Michael Zeira; Shoshana Reich; Orit Pappo; Israel Vl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

## Abstract ## Background Heparanase is an endo‐β‐D‐glucuronidase that cleaves heparan sulfate saccharide chains. The enzyme promotes cell adhesion, migration and invasion, and was shown to play a significant role in cancer metastasis and angiogenesis. ## Methods The present study focuses on the